This past week, President Vladimir V. Putin said that enough Sputnik V to fully inoculate 8.9 million people had been distributed in Russia since regulators approved the drug last August. Russia’s minister of industry said Monday he expected a quick ramp-up by April to twice that amount every month.
Russia’s vaccination campaign has fallen far behind that of most European nations and the United States. Russia has vaccinated 4.4 percent of its population, compared to 10 percent in the European Union and 26 percent in the United States.
The Kremlin this past week for the first time acknowledged that scarcity of the vaccine played a role in Mr. Putin’s decision to delay his own inoculation to avoid stimulating demand for shots before they became widely available outside the capital.
In January, when Mr. Putin became eligible for a shot under Russian rules based on his age, “production was not yet sufficient to fully meet demand in the regions,” said his spokesman, Dmitri S. Peskov.
It’s not clear how large a role the imports will play in alleviating scarcity, accelerating vaccinations and saving lives in Russia. But it positions Russia lower in the pecking order of vaccine geopolitics, as an importer rather than just an exporter.
Russian officials have chosen to highlight exports, however. “A vaccine for all humankind,” the Sputnik V website declares. State media has lavished attention on even relatively small shipments of tens or hundreds of thousands of doses to foreign countries.
Janice founded TceDar with an aim to bring relevant and unaltered news to the general public with a specific viewpoint for each story catered by the team. She is a proficient journalist who holds a reputable portfolio with proficiency in content analysis and research. With ample knowledge about the business industry, Janice also contributes her knowledge to the business section of the website.